Operating Profit Margin
since 2005
Calculation
Allergan PLC, operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating income (loss)1 | ÷ | Net revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | -27.63% | = | 100 | × | (4,445,300) | ÷ | 16,088,900) |
| Dec 31, 2018 | -39.57% | = | 100 | × | (6,247,600) | ÷ | 15,787,400) |
| Dec 31, 2017 | -37.15% | = | 100 | × | (5,921,200) | ÷ | 15,940,700) |
| Dec 31, 2016 | -12.53% | = | 100 | × | (1,825,500) | ÷ | 14,570,600) |
| Dec 31, 2015 | -20.00% | = | 100 | × | (3,014,500) | ÷ | 15,071,000) |
| Dec 31, 2014 | -9.71% | = | 100 | × | (1,267,700) | ÷ | 13,062,300) |
| Dec 31, 2013 | -4.88% | = | 100 | × | (423,200) | ÷ | 8,677,600) |
| Dec 31, 2012 | 5.42% | = | 100 | × | 320,800) | ÷ | 5,914,900) |
| Dec 31, 2011 | 11.70% | = | 100 | × | 536,200) | ÷ | 4,584,400) |
| Dec 31, 2010 | 8.56% | = | 100 | × | 305,400) | ÷ | 3,566,900) |
| Dec 31, 2009 | 13.75% | = | 100 | × | 383,900) | ÷ | 2,793,000) |
| Dec 31, 2008 | 14.12% | = | 100 | × | 358,128) | ÷ | 2,535,501) |
| Dec 31, 2007 | 10.24% | = | 100 | × | 255,660) | ÷ | 2,496,651) |
| Dec 31, 2006 | -21.33% | = | 100 | × | (422,096) | ÷ | 1,979,244) |
| Dec 31, 2005 | 13.27% | = | 100 | × | 218,512) | ÷ | 1,646,203) |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial data reveals notable fluctuations in both profitability and revenue over the analyzed period. Net revenues exhibit a consistent upward trajectory from 2005 through 2019, with the exception of some years showing slight volatility in the later part of the period. Starting at approximately 1.65 billion US dollars in 2005, net revenues increased markedly, peaking around 16.1 billion US dollars by 2019. This overall growth in revenue indicates effective sales expansion or enhanced market penetration over time.
Operating income displays a highly volatile pattern. After starting with a positive operating income near 218 million US dollars in 2005, the company experienced a significant operating loss in 2006, followed by a recovery phase extending through 2011, where operating income reached its highest point at over 536 million US dollars. From 2012 onward, operating income sharply declined, turning negative and culminating in substantial losses exceeding 6 billion US dollars by 2018, before a slight improvement in 2019.
The operating profit margin reflects the company's efficiency in managing costs relative to revenues and shows considerable instability. Initial margins were positive and stable above 10% through much of the early years, aside from a dip into negative territory in 2006. However, after 2011, the margin progressively deteriorates, reaching deeply negative values, with the lowest margin close to negative 39.57% in 2018. Although there is a marginal improvement in 2019, the margin remains significantly below zero, pointing to persistent operational challenges.
Overall, despite the steady growth in net revenues, the company faces declining operational profitability from 2012 onward, indicating rising expenses, potential restructuring costs, or other operational inefficiencies impacting earnings adversely. The data suggests the need for strategic review to restore profitability while maintaining revenue growth momentum.
- Net Revenues
- Consistent year-on-year growth from 1.65 billion to 16.1 billion US dollars between 2005 and 2019 with minor fluctuations late in the period.
- Operating Income
- Fluctuated with early recovery post-2006 losses, peaked in 2011, followed by a sustained decline reaching multi-billion dollar operating losses from 2013 onward.
- Operating Profit Margin
- Positive margins in the early years shifting to substantial negative margins after 2011, with the worst performance in 2018, slight recovery in 2019 but remaining negative.
Comparison to Competitors
Allergan PLC, operating profit margin, long-term trends, comparison to competitors
| Allergan PLC | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | -27.63% | 39.03% | 43.57% | 18.25% | 19.38% | 28.10% | 17.99% | 28.77% |
| Dec 31, 2018 | -39.57% | 19.49% | 45.55% | 17.11% | 37.83% | 37.77% | 15.53% | 20.84% |
| Dec 31, 2017 | -37.15% | 33.99% | 45.76% | 16.48% | 55.04% | 35.41% | 14.19% | 4.95% |
| Dec 31, 2016 | -12.53% | 36.60% | 44.74% | 16.29% | 58.87% | 27.38% | 13.40% | 0.58% |
| Dec 31, 2015 | -20.00% | 32.97% | 40.44% | 16.87% | 69.03% | 30.51% | 13.77% | -45.23% |
| Dec 31, 2014 | -9.71% | 17.09% | 32.03% | 17.23% | 62.37% | 29.74% | 14.82% | -119.30% |
| Dec 31, 2013 | -4.88% | 30.14% | 32.25% | 17.13% | 41.87% | 36.11% | 12.30% | -74.54% |
| Dec 31, 2012 | 5.42% | 31.65% | 33.52% | 17.33% | 42.67% | 33.20% | 11.85% | 0.15% |
| Dec 31, 2011 | 11.70% | — | 28.19% | 16.27% | 46.77% | -46.02% | 10.62% | 8.07% |
| Dec 31, 2010 | 8.56% | — | 37.82% | 16.41% | 53.62% | -21.23% | 11.72% | -485.51% |
| Dec 31, 2009 | 13.75% | — | 38.37% | 13.79% | 54.55% | -19.54% | 10.38% | -602.63% |
| Dec 31, 2008 | 14.12% | — | 35.50% | 14.72% | 52.68% | -37.67% | 11.71% | -263.65% |
| Dec 31, 2007 | 10.24% | — | 27.81% | 15.79% | 57.98% | -91.55% | 10.00% | -210.94% |
| Dec 31, 2006 | -21.33% | — | 27.71% | 15.82% | -29.32% | -169.68% | 6.38% | -105.86% |
| Dec 31, 2005 | 13.27% | — | 40.33% | 15.84% | 61.41% | -187.97% | 10.01% | -93.15% |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).